BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16120757)

  • 1. Suppressor of cytokine signalling 1 in lymphocytes regulates the development of intestinal inflammation in mice.
    Inagaki-Ohara K; Sasaki A; Matsuzaki G; Ikeda T; Hotokezaka M; Chijiiwa K; Kubo M; Yoshida H; Nawa Y; Yoshimura A
    Gut; 2006 Feb; 55(2):212-9. PubMed ID: 16120757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressor of cytokine signaling-1 regulates inflammatory bowel disease in which both IFNgamma and IL-4 are involved.
    Chinen T; Kobayashi T; Ogata H; Takaesu G; Takaki H; Hashimoto M; Yagita H; Nawata H; Yoshimura A
    Gastroenterology; 2006 Feb; 130(2):373-88. PubMed ID: 16472593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressor of cytokine signaling 1 stringently regulates distinct functions of IL-7 and IL-15 in vivo during T lymphocyte development and homeostasis.
    Ramanathan S; Gagnon J; Leblanc C; Rottapel R; Ilangumaran S
    J Immunol; 2006 Apr; 176(7):4029-41. PubMed ID: 16547238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44high memory T lymphocytes.
    Ilangumaran S; Ramanathan S; La Rose J; Poussier P; Rottapel R
    J Immunol; 2003 Sep; 171(5):2435-45. PubMed ID: 12928391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of suppressor of cytokine signaling 1 as a negative regulator for aberrant expansion of CD8alpha+ dendritic cell subset.
    Tsukada J; Ozaki A; Hanada T; Chinen T; Abe R; Yoshimura A; Kubo M
    Int Immunol; 2005 Sep; 17(9):1167-78. PubMed ID: 16091384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice.
    Horino J; Fujimoto M; Terabe F; Serada S; Takahashi T; Soma Y; Tanaka K; Chinen T; Yoshimura A; Nomura S; Kawase I; Hayashi N; Kishimoto T; Naka T
    Int Immunol; 2008 Jun; 20(6):753-62. PubMed ID: 18381351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses.
    Kontaki E; Boumpas DT; Tzardi M; Mouzas IA; Papadakis KA; Verginis P
    Autoimmunity; 2017 May; 50(3):170-181. PubMed ID: 28276713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells.
    Yu CR; Mahdi RM; Ebong S; Vistica BP; Gery I; Egwuagu CE
    J Biol Chem; 2003 Aug; 278(32):29752-9. PubMed ID: 12783879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease.
    Mizoguchi A; Mizoguchi E; Chiba C; Spiekermann GM; Tonegawa S; Nagler-Anderson C; Bhan AK
    J Exp Med; 1996 Mar; 183(3):847-56. PubMed ID: 8642289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1.
    Federici M; Giustizieri ML; Scarponi C; Girolomoni G; Albanesi C
    J Immunol; 2002 Jul; 169(1):434-42. PubMed ID: 12077274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of interferon-gamma in neonatal SOCS1-/- mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory disease.
    Bullen DV; Darwiche R; Metcalf D; Handman E; Alexander WS
    Immunology; 2001 Sep; 104(1):92-8. PubMed ID: 11576226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity.
    Fenner JE; Starr R; Cornish AL; Zhang JG; Metcalf D; Schreiber RD; Sheehan K; Hilton DJ; Alexander WS; Hertzog PJ
    Nat Immunol; 2006 Jan; 7(1):33-9. PubMed ID: 16311601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling.
    Wormald S; Zhang JG; Krebs DL; Mielke LA; Silver J; Alexander WS; Speed TP; Nicola NA; Hilton DJ
    J Biol Chem; 2006 Apr; 281(16):11135-43. PubMed ID: 16473883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of pro-inflammatory cytokines by TCR alpha beta+ and TCR gamma delta+ T cells in an experimental model of colitis.
    Simpson SJ; Holländer GA; Mizoguchi E; Allen D; Bhan AK; Wang B; Terhorst C
    Eur J Immunol; 1997 Jan; 27(1):17-25. PubMed ID: 9021993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor of cytokine signaling-1 in T cells and macrophages is critical for preventing lethal inflammation.
    Chong MM; Metcalf D; Jamieson E; Alexander WS; Kay TW
    Blood; 2005 Sep; 106(5):1668-75. PubMed ID: 15899915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOCS-1 regulates IL-15-driven homeostatic proliferation of antigen-naive CD8 T cells, limiting their autoimmune potential.
    Davey GM; Starr R; Cornish AL; Burghardt JT; Alexander WS; Carbone FR; Surh CD; Heath WR
    J Exp Med; 2005 Oct; 202(8):1099-108. PubMed ID: 16216888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of SOCS-1 on liver endotoxin tolerance development induced by a low dose of lipopolysaccharide are related to dampen NF-kappaB-mediated pathway.
    Liu ZJ; Liu XL; Zhao J; Shi YJ; Yan LN; Chen XF; Li XH; You HB; Xu FL; Gong JP
    Dig Liver Dis; 2008 Jul; 40(7):568-77. PubMed ID: 18378198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor of cytokine signaling 1 is required for the differentiation of CD4+ T cells.
    Catlett IM; Hedrick SM
    Nat Immunol; 2005 Jul; 6(7):715-21. PubMed ID: 15924143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-gamma on STAT3 and Smads.
    Tanaka K; Ichiyama K; Hashimoto M; Yoshida H; Takimoto T; Takaesu G; Torisu T; Hanada T; Yasukawa H; Fukuyama S; Inoue H; Nakanishi Y; Kobayashi T; Yoshimura A
    J Immunol; 2008 Mar; 180(6):3746-56. PubMed ID: 18322180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory Effect of Urine-derived Stem Cells on Inflammatory Bowel Diseases via Downregulating Th1/Th17 Immune Responses in a PGE2-dependent Manner.
    Zhou C; Wu XR; Liu HS; Liu XH; Liu GH; Zheng XB; Hu T; Liang ZX; He XW; Wu XJ; Smith LC; Zhang Y; Lan P
    J Crohns Colitis; 2020 Jun; 14(5):654-668. PubMed ID: 31841595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.